Smokable Drug Use Linked to Increased Severe Burns in Oregon | Analysis

A concerning trend is emerging in the landscape of substance use and its associated health risks: a rise in severe burn injuries linked to the increasing prevalence of smoking illicit drugs. New research from Oregon Health & Science University (OHSU) reveals a significant correlation between smokable drug use and hospital-level burn care, highlighting an under-recognized danger within the ongoing overdose epidemic.

Burn Injuries and Shifting Drug Use Patterns

The study, published in JAMA Internal Medicine, analyzed Oregon Medicaid data spanning nearly a decade, from April 2016 to March 2024. Researchers found that over half of individuals treated for severe burns in hospitals and emergency rooms likewise reported using smokable drugs other than tobacco. This finding is particularly striking given the nationwide shift in illicit drug consumption from injection to smoking, a change that has coincided with a slight decrease in overall overdose deaths. While the number of fatalities has dipped from a peak of around 100,000 annually earlier in the decade, this new data suggests a broadening spectrum of injury and disability linked to substance use.

“That’s a striking and concerning finding,” said Honora Englander, M.D., who directs an in-hospital addiction care team at OHSU. “Serious burns are an under-recognized risk associated with smoking drugs.” The research team initiated the study after observing a noticeable increase in severe burn cases, particularly at the Oregon Burn Center at Legacy Emanuel Medical Center in Portland.

The Role of Butane Torches

People who use illicit drugs frequently report using butane torches – typically intended for cooking – to heat substances for smoking. This practice introduces a significant risk of accidental burns, often severe enough to require specialized hospital care. The study doesn’t detail the specific substances being heated, but the association with butane torches points to a common method of consumption. Further research, as noted in a related study examining drug smoking practices and burn risks published in JAMA Network, is needed to fully understand the nuances of these practices.

Understanding the Data and Its Limitations

The OHSU analysis focused on data from Oregon Medicaid, which provides health coverage to a significant portion of the state’s population. While this offers a robust dataset, it’s vital to acknowledge the limitations. The findings may not be fully generalizable to populations outside of Oregon or to individuals not covered by Medicaid. The study establishes a correlation – a link – between smokable drug use and burn injuries, but it does not prove causation. It’s possible that other factors contribute to the increased risk of burns within this population. For example, individuals struggling with substance use may face socioeconomic challenges that increase their vulnerability to accidental injuries.

The study also relies on self-reported data regarding drug use, which can be subject to inaccuracies or underreporting. However, the sheer number of cases identified – over half of burn patients – suggests a strong and consistent association. The timeframe of the data (2016-2024) is also important; it captures a period of significant change in the drug landscape, including the rise of fentanyl and the shift towards smoking as a primary route of administration.

What Does This Mean for Public Health?

The findings underscore the need for increased awareness among healthcare providers, harm reduction specialists, and the public about the burn risks associated with smoking illicit drugs. This isn’t simply a matter of treating burns after they occur; it’s about preventing them in the first place. Harm reduction strategies could include providing education on safer smoking practices, such as using alternative heating methods that minimize the risk of burns, or promoting access to supervised consumption sites where individuals can use drugs in a safer environment.

The Oregon Health Authority (OHA) manages pharmacy benefits for various Medicaid members, including carve-out drugs and those not covered by Medicare Part D as detailed in their Pharmacy Quick Reference. While this document doesn’t directly address burn prevention, it highlights the existing infrastructure for delivering healthcare services to vulnerable populations, which could be leveraged to implement targeted prevention programs.

Beyond Oregon: A National Trend?

While the OHSU study focuses on data from Oregon, the researchers note that the shift from injection to smoking as the most common route of fatal overdoses is occurring nationwide. This suggests that the increased risk of burn injuries may not be limited to Oregon, but rather a broader public health concern. The study’s findings align with reports from other regions indicating a growing number of burn center admissions related to drug use. Further research is needed to determine the extent of this problem across the country and to identify effective prevention strategies.

The Evolving Overdose Crisis

The changing dynamics of the overdose crisis – from injection to smoking – present new challenges for public health officials. While efforts to reduce overdose deaths have focused largely on naloxone distribution and syringe exchange programs, these interventions may be less effective in addressing the risks associated with smoking. A more comprehensive approach is needed, one that recognizes the diverse ways in which people use drugs and the unique harms associated with each route of administration.

The rise in burn injuries also highlights the importance of addressing the underlying factors that contribute to substance use, such as poverty, trauma, and mental health issues. These are complex problems that require long-term solutions, but they are essential for creating a healthier and safer society.

Next Steps: Ongoing Surveillance and Expanded Research

Public health agencies are now focused on expanding surveillance efforts to better track the incidence of burn injuries related to drug use. This includes improving data collection at burn centers and emergency departments, as well as conducting targeted research to identify risk factors and effective prevention strategies. The OHSU research team plans to continue monitoring the situation in Oregon and to collaborate with colleagues across the country to gain a more comprehensive understanding of this emerging public health threat. Further studies will also explore the effectiveness of different harm reduction interventions in reducing the risk of burns among people who use smokable drugs.